期刊文献+

柳氮磺胺吡啶联合微生态制剂治疗溃疡性结肠炎的临床研究 被引量:2

Clinical study of sulfasalazine combined with microecological preparations in the treatment of ulcerative colitis
下载PDF
导出
摘要 目的:研究柳氮磺胺吡啶联合微生态制剂治疗溃疡性结肠炎的临床疗效。方法:选取2012年7月~2013年7月我院收治的溃疡性结肠炎患者36例(男性21例,女性15例)作为研究对象,均在我院接受治疗,实验组19例接受柳氮磺胺吡啶联合微生态制剂治疗,对照组17例接受单独柳氮磺胺吡啶治疗。根据患者治疗后临床症状、总有效率和不良反应比较两组治疗结果。结果:实验组和对照组相比,不良反应无明显差异,P〉0.05,无统计学意义。实验组总有效率达到100%,对照组总有效率76.47%。P〈O.05,差异有统计学意义。结论:柳氯磺胺吡啶联合微生态制剂治疗溃疡性结肠炎的方案效果显著,值得推广。 Objective: To study the clinical effects of sulfasalazine combined with microecological preparations in the treatment of ulcerative colitis. Methods: 36 patients with ulcerative colitis from 2012 July to 2013 July in our hospital were cases (male 21 cases, female 15 cases)as the re- search object, were treated in our hospital, which were divided into experimental group of 19 patients received sulfasalazine combined with Medilac-S treatment, 17 cases in the control group received single Liu nitrogen SULFAPYRIDINE treatment. According to the clinical symptoms of the patients after treatment, total effective rate and adverse reaction were compared between the two groups of treatment outcome. Results: compared to the experiment group and the control group, no significant difference, the adverse reaction of P〉O.05, no statistical significance. The experimental group total effectiveness 100%, the comparison group total effectiveness 76.47% P〈O.05, there was statistical significance. Conclusion: the effect of sulfasalazine combined with microecological preparations in the treatment of ulcerative colitis is significant, worthy of promotion.
作者 陈晓兵
出处 《内蒙古中医药》 2014年第20期88-89,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 柳氮磺胺吡啶 微生态制剂 结肠炎 sulfasalazine probiotics colitis
  • 相关文献

参考文献4

二级参考文献24

  • 1卢艺涛,高静,姚桂琴.溃疡性结肠炎患者相关细胞因子的实验性研究[J].现代预防医学,2005,32(7):735-736. 被引量:54
  • 2梁生林,唐志鹏.益生菌制剂在溃疡性结肠炎治疗中的作用[J].中国新药与临床杂志,2006,25(6):449-452. 被引量:9
  • 3李又平,阎立民,李林.仙白汤灌肠治疗慢性结肠炎疗效观察[J].宁夏医学杂志,1996,18(4):225-226. 被引量:1
  • 4张荣达.消化系统疾病与微生态[M].上海:上海科学技术出版社,2001:437-442.
  • 5Resta-Lenert S,Barrett KE.Live probiotics protect intes-tinal epithelialcells from the effects of infection with en-teroinvasive Escherichiacoli(EIEC)[J].Gut,2003,52:988-997.
  • 6Resta-Lenert S,Barrett KE.Live probiotics protect in-testinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli(EIEC)[J].Gut,2003,52:988-997.
  • 7Reddy KP,Markowitz JE,Ruchelli ED,et al.Lamina p rop ria and circulating interleukin28in newly and p re-viously diagnosed pediatric inflammatory bowel disease patients1[J].Dig Dis Sci,2007,52(2):3652-3721.
  • 8中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1024
  • 9EKBOM A. The epidemiology of IBD:a lot of data but little knowledge. How shall we proceed [ J ]. Inflamm Bowel Dis, 2004,10 ( 1 ) : 32 - 34.
  • 10Guamer F, Malagelada JR. Gut floram in health and disease [ J ]. Lan- cet,2003,361 (9356) :512 - 519.

共引文献29

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部